Search research articles
Contact Us
Filters
Showing results (351-360 of 28,845) with videos related to
Page
of 2,885
Sort By:
The Health Service Journal
|
December 16, 2003
Pharma focus. Puff adders
Stephen Chapman
Nature
|
August 20, 1992
Leeds inquiry
C Chapman
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
|
September 10, 2003
Ballooning of the vagina
K Chapman
Nature
|
October 24, 2003
Seeing is believing
Tim Chapman
Nature
|
October 24, 2003
High throughput goes 3D
Tim Chapman
Nature
|
October 24, 2003
Scanning the surface
Tim Chapman
Tobacco Control
|
December 3, 2003
"It is possible he is a kind of nut": how the tobacco industry quietly promoted Dr William Whitby
S Chapman
Modern Healthcare
|
July 9, 2004
Restring the safety net. Incremental changes aren't enough; a new system of care is needed
Thomas Chapman
Nature
|
July 2, 2004
Starting from scratch
Tim Chapman
Cardiology
|
January 1, 1994
Drug formularies--good or evil? A view using prescribing analyses and cost trends data
S Chapman
Page
of 2,885
Search research articles
Search
Showing results (351-360 of 28,845) with videos related to
Sort By:
Page
of 2,885
The Health Service Journal
|
December 16, 2003
Pharma focus. Puff adders
Stephen Chapman
Nature
|
August 20, 1992
Leeds inquiry
C Chapman
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
|
September 10, 2003
Ballooning of the vagina
K Chapman
Nature
|
October 24, 2003
Seeing is believing
Tim Chapman
Nature
|
October 24, 2003
High throughput goes 3D
Tim Chapman
Nature
|
October 24, 2003
Scanning the surface
Tim Chapman
Tobacco Control
|
December 3, 2003
"It is possible he is a kind of nut": how the tobacco industry quietly promoted Dr William Whitby
S Chapman
Modern Healthcare
|
July 9, 2004
Restring the safety net. Incremental changes aren't enough; a new system of care is needed
Thomas Chapman
Nature
|
July 2, 2004
Starting from scratch
Tim Chapman
Cardiology
|
January 1, 1994
Drug formularies--good or evil? A view using prescribing analyses and cost trends data
S Chapman
Page
of 2,885